New CEO Appointment A Clear Positive For Emergent BioSolutions [Seeking Alpha]
Emergent Biosolutions, Inc. (EBS)
Last emergent biosolutions, inc. earnings: 4/30 04:08 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.emergentbiosolutions.com
Company Research
Source: Seeking Alpha
The CEO's contract offers strong incentives for a stock price of over $15. Still, equity dilution is likely coming and the business remains highly levered. It's quite possible to see scenarios where EBS trades well above its current price, but a chance of wipe-out remains too. In my overall view, the risks appear weighted to the upside for EBS. Pharmaceutical company Emergent BioSolutions ( NYSE: EBS ) has appointed a new CEO replacing an interim CEO at the troubled company. This is a positive because the appointment of a credible CEO is a significant vote of confidence in a business in an unstable situation. I've written previously about EBS in August and December of 2023. In summary, though dilution is likely, if the company can regain historic profitability then a $30 stock price is conceivable, in the best case. That's in part because arguably government pharmaceutical contracts should be reliable over the medium term. Offsetting that, upside is a very high current debt
Show less
Read more
Impact Snapshot
Event Time:
EBS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EBS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EBS alerts
High impacting Emergent Biosolutions, Inc. news events
Weekly update
A roundup of the hottest topics
EBS
News
- Emergent Biosolutions lays off 300 people [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Reports First Quarter 2024 Financial ResultsGlobeNewswire
EBS
Earnings
- 3/6/24 - Miss
EBS
Sec Filings
- 5/2/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 5/1/24 - Form 8-K
- EBS's page on the SEC website